Detalles de la búsqueda
1.
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials.
Circulation
; 149(8): 574-584, 2024 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870970
2.
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
Am Heart J
; 272: 11-22, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458371
3.
Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 103(2): 260-267, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38173300
4.
Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians.
Catheter Cardiovasc Interv
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639154
5.
Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 103(3): 425-434, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314901
6.
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.
Am Heart J
; 263: 26-34, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094668
7.
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Catheter Cardiovasc Interv
; 101(3): 511-519, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36691863
8.
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv
; 101(6): 1134-1143, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036268
9.
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
Eur Heart J
; 43(7): e17-e25, 2022 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270529
10.
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
Lancet
; 398(10315): 1974-1983, 2021 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34793743
11.
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
N Engl J Med
; 381(21): 2032-2042, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556978
12.
Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis.
Cardiovasc Diabetol
; 21(1): 246, 2022 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36384656
13.
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
Catheter Cardiovasc Interv
; 100(4): 636-645, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36040717
14.
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.
J Thromb Thrombolysis
; 53(2): 380-389, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34386899
15.
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
J Thromb Thrombolysis
; 53(1): 20-29, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347202
16.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Eur Heart J
; 42(45): 4624-4634, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662382
17.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Eur Heart J
; 42(45): 4683-4693, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423374
18.
Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
Catheter Cardiovasc Interv
; 97(1): 63-71, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406998
19.
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
Catheter Cardiovasc Interv
; 97(7): 1387-1396, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507598
20.
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Catheter Cardiovasc Interv
; 98(4): E494-E500, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34032363